Advertisement.

CNCR Projected Dividend Yield

Range Cancer Therapeutics ETF/ETF Series Solutions ( NASDAQ : CNCR )

19 YEAR PERFORMANCE RESULTS

CNCR Dividend History Detail
CNCR Dividend News
CNCR Competitors News

# of Shares: 0

Closing Price: 13.03

Current Market Value: 0.00

Cost Basis: 0.00

Date Acquired:

Dividend Cash Flow
Year	Annual Dividend	Dividend Growth	# of Shares	Annual Dividend Income	Yield On Cost %
2016	0.11	0%	0	$ 0.00	0.00%
2017	0.00	0%	0	$ 0.00	0.00%
2018	0.35	0%	0	$ 0.00	0.00%
2019	0.00	0%	0	$ 0.00	0.00%
2020	0.00	0%	0	$ 0.00	0.00%
2022	0.00	0%	0	$ 0.00	0.00%
2023	0.00	0%	0	$ 0.00	0.00%
2024	0.00	0%	0	$ 0.00	0.00%
2025	0.00	0%	0	$ 0.00	0.00%
2026	0.00	0%	0	$ 0.00	0.00%
Using the current years Dividend Growth rate of 0% and projecting 0% forward the annual dividend income in 10/yrs would be $ 0.00 with a yield on cost % of 0.00%
Rolling Last 4 qtrs dividends total $ 0.00 and Previous last 4 qtrs dividends total $ 0.00
Dividend 1 Yr Growth = ( 0.00 – 0.00 ) × 100 = 0% (Click the Edit pencil if you want to modify the forward dividend growth rate projection) 0.00

Year	Declaration Date	Ex-Dividend Date	Record Date	Payable Date	Dividend $ Amount
2021	Dec 28, 2021	Dec 29, 2021	Dec 30, 2021	Dec 31, 2021	1.8533
2021	Dec 29, 2020	Dec 30, 2020	Dec 31, 2020	Jan 04, 2021	0.2881
2021 Total:					2.1415

X

Search Dividend Investor